178 related articles for article (PubMed ID: 33381076)
1. Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome.
Martin LJ; Wong M
Front Neurol; 2020; 11():592851. PubMed ID: 33381076
[TBL] [Abstract][Full Text] [Related]
2. Roflupram alleviates autophagy defects and reduces mutant hSOD1-induced motor neuron damage in cell and mouse models of amyotrophic lateral sclerosis.
Huo D; Liang W; Wang D; Liu Q; Wang H; Wang Y; Zhang C; Cong C; Su X; Tan X; Zhang W; Han L; Zhang D; Wang M; Feng H
Neuropharmacology; 2024 Apr; 247():109812. PubMed ID: 38218579
[TBL] [Abstract][Full Text] [Related]
3. Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death.
Martínez P; Silva M; Abarzúa S; Tevy MF; Jaimovich E; Constantine-Paton M; Bustos FJ; van Zundert B
bioRxiv; 2024 May; ():. PubMed ID: 38826246
[TBL] [Abstract][Full Text] [Related]
4. GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis.
Martin LJ; Fancelli D; Wong M; Niedzwiecki M; Ballarini M; Plyte S; Chang Q
Front Cell Neurosci; 2014; 8():433. PubMed ID: 25565966
[TBL] [Abstract][Full Text] [Related]
5. The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis.
Pikatza-Menoio O; Elicegui A; Bengoetxea X; Naldaiz-Gastesi N; López de Munain A; Gerenu G; Gil-Bea FJ; Alonso-Martín S
J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357138
[TBL] [Abstract][Full Text] [Related]
6. SERCA1 Overexpression in Skeletal Muscle Attenuates Muscle Atrophy and Improves Motor Function in a Mouse Model of ALS.
Mázala DAG; Chen D; Chin ER
J Neuromuscul Dis; 2024; 11(2):315-326. PubMed ID: 38217607
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory Effects of a Novel Herbal Extract in the Muscle and Spinal Cord of an Amyotrophic Lateral Sclerosis Animal Model.
Lee SH; Cai M; Yang EJ
Front Neurosci; 2021; 15():743705. PubMed ID: 34858128
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of differential gene expression in lower motor neurons isolated by laser capture microdissection from post-mortem ALS spinal cords.
Swindell WR
Front Genet; 2024; 15():1385114. PubMed ID: 38689650
[TBL] [Abstract][Full Text] [Related]
9. Selective vulnerability of motor neuron types and functional groups to degeneration in amyotrophic lateral sclerosis: review of the neurobiological mechanisms and functional correlates.
Ovsepian SV; O'Leary VB; Martinez S
Brain Struct Funct; 2024 Jan; 229(1):1-14. PubMed ID: 37999738
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches.
Kubat GB; Picone P
Neurol Sci; 2024 Apr; ():. PubMed ID: 38676818
[TBL] [Abstract][Full Text] [Related]
11. Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?
Scaricamazza S; Salvatori I; Ferri A; Valle C
Cells; 2021 Mar; 10(3):. PubMed ID: 33801336
[TBL] [Abstract][Full Text] [Related]
12. ALS mutations in both human skeletal muscle and motoneurons differentially affects neuromuscular junction integrity and function.
Badu-Mensah A; Guo X; Nimbalkar S; Cai Y; Hickman JJ
Biomaterials; 2022 Oct; 289():121752. PubMed ID: 36084484
[TBL] [Abstract][Full Text] [Related]
13. Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease.
Ding Q; Kesavan K; Lee KM; Wimberger E; Robertson T; Gill M; Power D; Chang J; Fard AT; Mar JC; Henderson RD; Heggie S; McCombe PA; Jeffree RL; Colditz MJ; Hilliard MA; Ng DCH; Steyn FJ; Phillips WD; Wolvetang EJ; Ngo ST; Noakes PG
Acta Neuropathol Commun; 2022 Apr; 10(1):61. PubMed ID: 35468848
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.
Verma S; Khurana S; Vats A; Sahu B; Ganguly NK; Chakraborti P; Gourie-Devi M; Taneja V
Mol Neurobiol; 2022 Mar; 59(3):1502-1527. PubMed ID: 34997540
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis.
Cunha-Oliveira T; Montezinho L; Simões RF; Carvalho M; Ferreiro E; Silva FSG
Cells; 2024 Jan; 13(3):. PubMed ID: 38334639
[TBL] [Abstract][Full Text] [Related]
16. Secreted Metabolome of ALS-Related hSOD1(G93A) Primary Cultures of Myocytes and Implications for Myogenesis.
Stella R; Bonadio RS; Cagnin S; Andreotti R; Massimino ML; Bertoli A; Peggion C
Cells; 2023 Nov; 12(23):. PubMed ID: 38067180
[TBL] [Abstract][Full Text] [Related]
17. Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics.
Duranti E; Villa C
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002264
[TBL] [Abstract][Full Text] [Related]
18. Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis.
Richardson PJ; Smith DP; de Giorgio A; Snetkov X; Almond-Thynne J; Cronin S; Mead RJ; McDermott CJ; Shaw PJ
Transl Neurodegener; 2023 Oct; 12(1):47. PubMed ID: 37828541
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle in amyotrophic lateral sclerosis.
Shefner JM; Musaro A; Ngo ST; Lunetta C; Steyn FJ; Robitaille R; De Carvalho M; Rutkove S; Ludolph AC; Dupuis L
Brain; 2023 Nov; 146(11):4425-4436. PubMed ID: 37327376
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic Lateral Sclerosis Pathoetiology and Pathophysiology: Roles of Astrocytes, Gut Microbiome, and Muscle Interactions via the Mitochondrial Melatonergic Pathway, with Disruption by Glyphosate-Based Herbicides.
Anderson G
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
